Healthcare · National
Sellas’ cancer vaccine extends survival in blood cancer trial, company says
The vaccine, called galinpepimut-S or GPS, was tested in patients with acute myeloid leukaemia, a fast-growing cancer of the blood and bone marrow
Verified Timeline
No verified timeline updates.
What is your view on “Sellas’ cancer vaccine extends survival in blood cancer trial, company says”?
This is self-selected reader participation, not representative scientific polling.

